[HTML][HTML] Total neoadjuvant therapy in rectal cancer: the evidence and expectations

L Boublikova, A Novakova, J Simsa… - Critical Reviews in …, 2023 - Elsevier
Current management of locally advanced rectal cancer achieves high cure rates, distant
metastatic spread being the main cause of patients' death. Total neoadjuvant therapy (TNT) …

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment

WH Gmeiner - Cancers, 2024 - mdpi.com
Simple Summary Colorectal cancer is a leading cause of cancer mortality, and its incidence
is rapidly increasing worldwide. Colorectal cancer is considered a single entity based on …

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

A Yousef, M Yousef, S Chowdhury, K Abdilleh… - NPJ Precision …, 2024 - nature.com
The relevance of KRAS mutation alleles to clinical outcome remains inconclusive in
pancreatic adenocarcinoma (PDAC). We conducted a retrospective study of 803 patients …

Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival

M Yousef, A Yousef, S Chowdhury… - JAMA …, 2024 - jamanetwork.com
Importance Disparity in overall survival (OS) and differences in the frequency of driver gene
variants by race and ethnicity have been separately observed in patients with colorectal …

Serum tumor markers and outcomes in patients with Appendiceal Adenocarcinoma

A Yousef, M Yousef, MA Zeineddine, A More… - JAMA Network …, 2024 - jamanetwork.com
Importance Serum tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 19-
9 (CA19-9), and cancer antigen 125 (CA125) have been useful in the management of …

The national burden of colorectal cancer in the United States from 1990 to 2019

S Alsakarneh, F Jaber, A Beran, M Aldiabat, Y Abboud… - Cancers, 2024 - mdpi.com
Simple Summary Colorectal cancer (CRC) is a significant global health concern, ranking as
the second leading cause of cancer-related deaths. Despite an overall decline in CRC rates …

Elevated BEAN1 expression correlates with poor prognosis, immune evasion, and chemotherapy resistance in rectal adenocarcinoma

T Shapaer, Y Chen, Y Pan, Z Wu, T Tang, Z Zhao… - Discover Oncology, 2024 - Springer
Background The BEAN1 gene, primarily studied in neurodegenerative diseases, has been
scarcely studied in the context of cancers. Our research examines BEAN1 expression …

Enhanced therapeutic efficacy of the nanoscale fluoropyrimidine polymer CF10 in a rat colorectal cancer liver metastasis model

CC Okechukwu, X Ma, N Sah, C Mani, K Palle… - Cancers, 2024 - mdpi.com
Simple Summary Liver metastases are a major cause of colorectal cancer mortality. To
combat this, chemotherapy is widely used but generally does not result in long-term survival …

[HTML][HTML] Precision Medicine for Metastatic Colorectal Cancer: Where Do We Stand?

PW Underwood, TM Pawlik - Cancers, 2024 - mdpi.com
Metastatic colorectal cancer is a leading cause of cancer-related death across the world.
The treatment paradigm has shifted away from systemic chemotherapy alone to include …

Clinical Prediction Models for Prognosis of Colorectal Liver Metastases: A Comprehensive Review of Regression-Based and Machine Learning Models

S Kokkinakis, IA Ziogas, JD Llaque Salazar, DP Moris… - Cancers, 2024 - mdpi.com
Simple Summary Interest in stratification of prognosis for patients with colorectal liver
metastases is growing. Numerous clinical prediction models have been developed for this …